First Danish Hospital Signs INTERCEPT Platelet Agreement With Cerus Corporation

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that Aalborg University Hospital, Denmark, signed a five year project collaboration agreement for the INTERCEPT Blood System for platelets.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC